Secretin and autism: A two-part clinical investigation

Journal of Autism and Developmental Disorders

Volumn 30, Issue 2, 2000, Pages 87-94

  Chez, Michael G ^a,b   Buchanan, Cathleen P ^a   Bagan, Bradley T ^a   Hammer, Michael S ^a   McCarthy, Karla S ^a   Ovrutskaya, Irina ^a   Nowinski, Caralynn V ^a   Cohen, Zamia S ^a  

^a Lake Forest Hospital   (United States)

^b Pediatric Neurology   (United States)

Author keywords

Autism; Secretin

Indexed keywords

GASTROINTESTINAL HORMONE; PLACEBO; SECRETIN;

ARTICLE; AUTISM; BEHAVIOR; CHILD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HORMONAL THERAPY; HORMONE ACTION; HUMAN; LANGUAGE; MALE; PRIORITY JOURNAL; RATING SCALE;

EID: 0343294374     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005443119324     Document Type: Article

References (20)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.) Washington, DC: Author.
2. Bardenstein, R., Chez, M. G., Helfand, B. T., Buchanan, C. P., & Zucker, M. (1998). Improvement in EEG and clinical function in pervasive developmental delay (PDD): Effect of valproic Acid. Neurology, 50, A86.
3. Chez, M. G., & Buchanan, C. P. (1996). Clinical spectrum of patients referred for Landau-Kleffner syndrome previously diagnosed with pervasive developmental delay or autism: EEG, HMPAO SPECT, and steroid response data. Neurology, 46, A115.
4. Chez, M. G., & Buchanan, C. P. (1997). Age of regression of language and behavior in children referred for pervasive developmental delay correlates with severity of epileptiform activity on 24-hour EEG. Epilepsia, 38, 50.
5. Chez, M., Buchanan, C., Zucker, M., & May, B. (1997). Value of 24 hour EEG versus routine EEG in detecting occult epileptiform activity in children with pervasive developmental delay. Annals of Neurology, 42, 509.
6. Chez, M. G., Buchanan, C. P., Field-Chez, M., Loeffel, M. F., & Hammer, M. S. (1998). Treatment of electroencephalographic epileptiform activity on overnight EEG studies in children with pervasive developmental disorder or autism: Defining similarities to the Landau-Kleffner syndrome. Journal of Developmental and Learning Disorders, 2, 217-229.
7. Chez, M., Buchanan, C., Loeffel, M., Field-Chez, M., Nowinski, C., Bardenstein, R., Hammer, M. (1998). Practical treatment with pulse dose corticosteroids in pervasive developmental delay or autistic patients with abnormal epileptiform sleep EEG and language delay. In M. V. Perat (Ed.), New developments in child neorology (pp. 695-698). Bologna, Italy: Monduzzi Editore.
8. Chez, M. G., Loeffel, M., & Buchanan, C. (1998). Pulse high-dose steroids as combination therapy with valproic acid in epileptic aphasia patients with pervasive developmental delay or autism. Annals of Neurology, 44, 539.
9. Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287-295.
10. Happé, F., & Frith, U. (1991). Is Autism a pervasive developmental disorder? How useful is the "PDD" label. Journal of Child Psychology and Psychiatry, 32, 1167-1168.
11. Horvath, K., Stefanatos, G., Sokolski, K. N., Watchel, R., Nabors, L., & Tildon, J. T. (1998). Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians, 9, 9-15.
12. Kienle, G. S., & Keine, H. (1996). Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Alternative Therapies in Health Medicine, 2 (6, 39-54)
13. Maris, E. (1998). Covariance adjustment vs. gain scores-revisited. Psychological Methods, 3, 309-327.
14. Montgomery, G. H., & Kirsch, I. (1997). Classical conditioning and the placebo effect. Pain, 72, 107-113.
15. Perry, R., & Bangaru, B. S. (1998). Secretin and autism. Journal of Child and Adolescent Psychopharmacology, 8, 247-248.
16. Plioplys, A. V. (1994). Autism: Electroencephalogram abnormalities and clinical improvement with valproic acid. Archives of Pediatric and Adolescent Medicine, 148, 220-222.
17. Schopler, E., Reichler, R. J., & Renner, B. R. (1988). The Childhood Autism Rating Scale: CARS. Los Angeles, CA: Western Psychological Sciences.
18. Stefanatos, G. A., Grover, W., & Geller, E. (1995). Case study: Corticosteroid treatment of language regression in pervasive developmental disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1107-1111.
19. Trauner, D. A., Nabangchng, C., Ballantyne, A., & Tecoma, E. (1997). Developmental aphasia with epileptiform abnormalities on EEG: Clinical features and response to prednisone. Annals of Neurology, 42, 465.
20. Volkmar, F. R., & Nelson, D. S. (1990), Seizure disorders in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 127-129.